A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback